Volume 19, Issue 6, Supplement , Pages S9-S17, June 2008
Food and Drug Administration–approved Endovascular Repair Devices for Abdominal Aortic Aneurysms: A Review
Endovascular treatment of infrarenal abdominal aortic aneurysm (AAA) offers a less invasive alternative to conventional open repair. Currently, only four devices are Food and Drug Administration (FDA)–approved for use in endovascular aneurysm repair (EVAR) of AAA in the United States. All four devices are associated with a high technical success rate and less morbidity than open surgical repair. Each device has its inherent design advantages and disadvantages that must be matched with patient and AAA characteristics. This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.
Abbreviations: AAA, abdominal aortic aneurysm, EVAR, endovascular aneurysm repair, FDA, Food and Drug Administration
To access this article, please choose from the options below
J.R.L. serves on the advisory boards of Cordis (Warren, NJ), Boston Scientific (Natick, MA), Medtronic (Sunnyvale, CA), ev3 (Plymouth, MN), and Edwards Lifesciences (Irvine, CA).
PII: S1051-0443(08)00005-5
doi:10.1016/j.jvir.2007.12.452
© 2008 SIR. Published by Elsevier Inc. All rights reserved.
Volume 19, Issue 6, Supplement , Pages S9-S17, June 2008
